<DOC>
	<DOCNO>NCT00639236</DOCNO>
	<brief_summary>The use inhale hypertonic saline extensively document asthma , bronchiectasis , cystic fibrosis COPD method bronchial challenge sputum induction , study evaluate others endpoint require . The objective study analyse effect inhale hypertonic saline compare placebo respect functional exercise capacity , dyspnoea quality life . In double-blind randomised parallel placebo-controlled trial , conduct Clínicas Integradas Evangelical Faculty Paraná , sixty-eight patient ( age 67 ± 6.5 year ; FEV1 38.9 ± 16.2 predict ) randomise inhale 3 % hypertonic saline ( n=34 ) placebo ( n=34 ) , combine program exercise , three time week , 8-weeks .</brief_summary>
	<brief_title>Effectiveness Safety Inhaling Hypertonic Saline Patients With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>Background : The use inhale hypertonic saline extensively document asthma , bronchiectasis , cystic fibrosis COPD method bronchial challenge sputum induction , study evaluate others endpoint require . Objective : To analyse effect inhale hypertonic saline compare placebo respect functional exercise capacity , dyspnoea quality life . Design Setting : This double-blind randomise parallel placebo-controlled trial , conduct Clínicas Integradas Evangelical Faculty Paraná . Methods : sixty-eight patient ( age 67 ± 6.5 year ; FEV1 38.9 ± 16.2 predict ) randomise inhale 3 % hypertonic saline ( n=34 ) placebo ( n=34 ) , combine program exercise , three time week , 8-weeks . Results : After 8-weeks treatment period , group show significant change functional exercise capacity ( p &lt; 0,001 ) , dyspnoea ( p &lt; 0,001 ) quality life . When compare group , significant improvement placebo group functional exercise capacity ( p &lt; 0,001 ) . Conclusion : present study conclude inhale HS reduces functional capacity , compare placebo associate appearance cough bronchial spasm .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Patients COPD diagnosis base clinical finding spirometry ( FEV1 &lt; 60 % predict ) accord American Thoracic Society20 clinically stable least last month age 40 75 year old exsmokers without severe and/or unstable heart disease pathologic condition could impair physical activity ( e.g. , cerebrovascular disease rheumatism ) , include . Respiratory medication permit , prior throughout duration study , bronchodilator corticosteroid . Patients unstable lung disease ( evidenced administration intravenous antibiotic four week screen ) evidence reactive airway ( FEV1 ≥ 20 percent response bronchodilatation clinical diagnosis asthma ) exclude</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>COPD</keyword>
	<keyword>Hypertonic saline</keyword>
	<keyword>Quality life</keyword>
	<keyword>Dyspnoea .</keyword>
</DOC>